1. Home
  2. HLIT vs NUVB Comparison

HLIT vs NUVB Comparison

Compare HLIT & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLIT
  • NUVB
  • Stock Information
  • Founded
  • HLIT 1988
  • NUVB 2018
  • Country
  • HLIT United States
  • NUVB United States
  • Employees
  • HLIT N/A
  • NUVB N/A
  • Industry
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HLIT Technology
  • NUVB Health Care
  • Exchange
  • HLIT Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • HLIT 1.2B
  • NUVB 1.1B
  • IPO Year
  • HLIT 1995
  • NUVB N/A
  • Fundamental
  • Price
  • HLIT $10.63
  • NUVB $5.23
  • Analyst Decision
  • HLIT Buy
  • NUVB Strong Buy
  • Analyst Count
  • HLIT 6
  • NUVB 7
  • Target Price
  • HLIT $12.10
  • NUVB $8.43
  • AVG Volume (30 Days)
  • HLIT 691.8K
  • NUVB 8.5M
  • Earning Date
  • HLIT 11-03-2025
  • NUVB 11-03-2025
  • Dividend Yield
  • HLIT N/A
  • NUVB N/A
  • EPS Growth
  • HLIT 16.91
  • NUVB N/A
  • EPS
  • HLIT 0.58
  • NUVB N/A
  • Revenue
  • HLIT $689,084,000.00
  • NUVB $14,355,000.00
  • Revenue This Year
  • HLIT N/A
  • NUVB $283.91
  • Revenue Next Year
  • HLIT $25.21
  • NUVB $340.13
  • P/E Ratio
  • HLIT $18.48
  • NUVB N/A
  • Revenue Growth
  • HLIT 24.14
  • NUVB 900.35
  • 52 Week Low
  • HLIT $7.80
  • NUVB $1.54
  • 52 Week High
  • HLIT $13.75
  • NUVB $5.55
  • Technical
  • Relative Strength Index (RSI)
  • HLIT 59.19
  • NUVB 72.98
  • Support Level
  • HLIT $10.25
  • NUVB $5.06
  • Resistance Level
  • HLIT $10.87
  • NUVB $5.55
  • Average True Range (ATR)
  • HLIT 0.25
  • NUVB 0.33
  • MACD
  • HLIT 0.01
  • NUVB 0.10
  • Stochastic Oscillator
  • HLIT 68.15
  • NUVB 83.79

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: